Repurposing Tecfidera for cancer

Aging (Albany NY). 2016 Jul;8(7):1289-90. doi: 10.18632/aging.101001.

Authors

Laurence Booth¹, Mark Malkin², Paul Dent¹

Affiliations

¹ Departments of Biochemistry and Molecular Biology, Virginia Commonwealth University School of Medicine, and the Massey Cancer Center, Richmond, VA 23298, USA.
² Department of Neurology, Virginia Commonwealth University, Richmond, VA 23298, USA.

No abstract available

Keywords: Jakafi; Tecfidera; dimethyl fumarate (DMF); glioblastoma multiforme; monomethyl fumarate (MMF); oncology; ruxolitinib.

Publication types

Editorial

MeSH terms

Antineoplastic Agents / pharmacology*
Dimethyl Fumarate / pharmacology*
Drug Repositioning*
Humans
Immunosuppressive Agents / pharmacology
Neoplasms / drug therapy*

Substances

Antineoplastic Agents
Immunosuppressive Agents
Dimethyl Fumarate

Grants and funding

R01 CA192613/CA/NCI NIH HHS/United States